Search results
Gritstone bio appoints new board member amid growth phase By Investing.com
Investing.com· 4 hours agoGritstone bio, Inc. (NASDAQ:GRTS), a clinical-stage biotechnology company, announced today the...
Akari Therapeutics announces leadership shakeup and cost savings By Investing.com
Investing.com· 6 hours agoAkari Therapeutics, Plc (NASDAQ: NASDAQ:AKTX), a biotechnology company focused on autoimmune and...
With 53% ownership, Vir Biotechnology, Inc. (NASDAQ:VIR) boasts of strong institutional backing
Simply Wall St. via Yahoo Finance· 3 days agoKey Insights Institutions' substantial holdings in Vir Biotechnology implies that they have...
What's in Store for Puma Biotechnology (PBYI) in Q1 Earnings?
Zacks via Yahoo Finance· 5 days agoOn Puma Biotechnology's (PBYI) first-quarter 2024 earnings call, investors' focus is likely to be on...
Nautilus Biotechnology Inc (NAUT) Q1 2024 Earnings: Narrower Loss Than Expected
GuruFocus.com via Yahoo Finance· 1 day agoInterest Income: Interest income decreased to $2.87 million from $3.10 million in the previous year. On April 30, 2024, Nautilus Biotechnology Inc (NASDAQ:NAUT) disclosed ...
Q1 2024 Nautilus Biotechnology Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 21 hours agoParticipants Sujal Patel; Founder & CEO; Nautilus Biotechnology Inc Parag Mallick; Co-Founder, Chief Scientist; Nautilus Subsidiary Inc Anna Mowry; Chief Financial Officer ...
Federated Hermes Inc. Acquires New Position in Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA)
ETF DAILY NEWS· 12 hours agoFederated Hermes Inc. acquired a new stake in Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA – Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the ...
Signaturefd LLC Purchases 867 Shares of Galapagos NV (NASDAQ:GLPG)
ETF DAILY NEWS· 10 hours agoSignaturefd LLC raised its position in shares of Galapagos NV (NASDAQ:GLPG – Free Report) by 78.6% in the fourth quarter, according to the company in its most recent filing with the Securities ...
Ginkgo Bioworks: Buy, Sell, or Hold?
Motley Fool via Yahoo Finance· 1 day agoIn a world where biotechnology is always becoming more sophisticated, manufacturing-oriented biotech businesses like Ginkgo Bioworks (NYSE: DNA) are...
Nautilus Biotechnology Inc (NAUT) Q1 2024 Earnings Call Transcript Highlights: A Detailed ...
GuruFocus.com via Yahoo Finance· 16 hours agoExplore key financial outcomes and strategic insights from Nautilus Biotechnology's first quarter of 2024, emphasizing growth in expenses and future expectations.
